Abstract

Background: This study was undertaken to determine how many patients are screened by obstetrician and gynecologist and how many undergo biopsy with positive result for malignancy or benign disease, to determine stage of breast cancer diagnosed during screening. Aim: The main aim of the study is to assess how many patients are diagnosed with breast cancer during routine screening and their stage. Methods: It is a study conducted from 1st April 2022 till 31st March 2023. All women who presented to obstetrician / gynecologist with breast symptoms or concerns were included. The breast cancer screening methods employed were: mammography or ultrasonography, breast self-examination (BSE), and physical examination. To confirm diagnosis, if indicated by BI-RADS staging in mammography or ultrasonography, core –needle biopsy was done.

Description